STOCK TITAN

[Form 4] STEPAN CO Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Stepan Co President & CEO Luis Rojo reported equity awards that increase his stake in the company. On March 2, 2026, he received 19,976 Restricted Stock Units, 39,952 performance shares, and a Stock Appreciation Right covering 57,241 shares, all at a stated price of $0.00 per unit.

Each RSU and performance share represents a contingent right to receive one share of Stepan common stock, with RSUs vesting in equal installments over three years and performance shares vesting after certification of performance for the period ending December 31, 2028. On February 27, 2026, he also acquired 56.765 shares of common stock at $52.51 per share, bringing his directly held common stock to 15,697.666 shares, plus 511.83 shares held indirectly through an ESOP II trust.

Positive

  • None.

Negative

  • None.

Insights

CEO received sizable stock-based awards, aligning pay with long-term performance.

The transactions show Luis Rojo, President & CEO of Stepan Co, receiving RSUs, performance shares, and a stock appreciation right on March 2, 2026. These are non-cash equity awards, with stated grant prices of $0.00 per unit.

RSUs vest ratably over three years, while performance shares vest only after certification of performance for the period ending December 31, 2028. This structure ties a meaningful portion of potential value to multi-year service and performance conditions rather than immediate cash pay.

The CEO also received a smaller common stock award of 56.765 shares at $52.51 on February 27, 2026. Overall, these grants appear to be routine executive compensation, so the information is directionally neutral for investors, though it modestly increases the CEO’s direct and indirect equity exposure.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rojo Luis

(Last) (First) (Middle)
1101 SKOKIE BOULEVARD, SUITE 500

(Street)
NORTHBROOK IL 60062

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STEPAN CO [ SCL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/27/2026 A 56.765 A $52.51 15,697.666 D
Common Stock 511.83 I By Esop II Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 03/02/2026 A 19,976 03/02/2027(2) 03/02/2029 Restricted Stock Units 19,976 $0 19,976 D
Performance Shares (3) 03/02/2026 A 39,952 (4) (4) Common Stock 39,952 $0 39,952 D
Stock Appreciation Right $17.47 03/02/2026 A 57,241 03/02/2027(2) 03/03/2036 Common Stock 57,241 $0 57,241 D
Explanation of Responses:
1. Each RSU represents a contingent right to receive one share of Stepan Company common stock.
2. Vests ratably over three years beginning on the date shown.
3. Each performance share represents a contingent right to receive one share of Stepan Company common stock.
4. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.
/s/ James A. Hart, Attorney-in-Fact for Luis Rojo 03/04/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Stepan

NYSE:SCL

View SCL Stock Overview

SCL Rankings

SCL Latest News

SCL Latest SEC Filings

SCL Stock Data

1.06B
21.28M
Specialty Chemicals
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Link
United States
NORTHFIELD